Future Directions and Unmet Needs

Panelists discuss how ongoing challenges in tardive dyskinesia (TD) management include delayed recognition, limited patient education, and fragmented care coordination. Despite advances in therapy, many patients still experience stigma and gaps in support.

Panelists discuss how pharmacists can drive progress by advocating for earlier screening, expanding patient awareness, and leading initiatives that integrate TD management into broader mental health care. Research into long-term outcomes and new therapeutic options will continue to shape the pharmacist’s evolving role.

Panelists discuss how future success will rely on education, access, and collaboration between health care disciplines. Pharmacists will remain at the forefront of bridging clinical evidence with everyday patient care.